Jasper Claessen (PhD) is a Senior Advisor at the Department of Pharmaceutical affairs, at the Dutch Ministry of Health. He works on policies regarding the development of innovative medicines, with a special interest in the synergy between public and private interests in medicine development. He coordinates the Dutch policies aimed to stimulate R&D into novel antimicrobials, and represents the Dutch Ministry of Health in several national and international organizations that aim to tackle the AMR crisis. Furthermore, he is involved in the Dutch crisis response team aimed at making new COVID-19 medication accessible, and coordinates a comprehensive study into the financial ecosystem surrounding novel drug development. Prior to joining the ministry, he worked for several years as an innovation consultant building public/private R&D partnerships, and attracting funding for drug development programs and other health innovation initiatives. Trained as a molecular biologist, Jasper Claessen spend many years as an academic researcher at MIT and Cambridge University.